Inventor · disambiguated record
Carmen Blanco Aparicio
Also filed as: BLANCO APARICÍO CARMEN · BLANCO-APARICIO CARMEN
5 granted patents·3 pending applications·6 citations·filing 1997–2022
67Inventor score
Files withFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS1FUNDACION DEL SECTOR PUBLLCO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III1FUNDACIÓN CENTRO NAC DE INVESTIG ONCOLOGICAS CARLOS III1FUNDACIÓN CENTRO NAC DE INVESTIG ONCOLÓGICAS CARLOS III1PASTOR FERNÁNDEZ JOAQUIN1
Top patents by PatentIndex Score
8 records- 0170US9284334B2Macrocyclic compounds as protein kinase inhibitorsPASTOR FERNÁNDEZ JOAQUIN·Filed 2012·Granted Mar 15, 2016·3 cites·11 claims
- 0247US2025042918A1CompoundsFUNDACION DEL SECTOR PUBLLCO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III·Filed 2022·Application pending·0 cites
- 0344US2024199630A1Imidazo[1,2-b]pyridazine based tricyclic compounds as inhibitors of haspin and therapeutic uses thereofFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS·Filed 2022·Application pending·0 cites
- 0431US9808466B2Macrocyclic compounds as protein kinase inhibitorsFUNDACIÓN CENTRO NAC DE INVESTIG ONCOLOGICAS CARLOS III·Filed 2016·Granted Nov 7, 2017·0 cites·9 claims
- 0530US6379959B1Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agentsUNIV BARCELONA AUTONOMA·Filed 1997·Granted Apr 30, 2002·3 cites·13 claims
- 0626US2013065883A1Triazolo [4, 5- B] Pyridin DerivativesPASTOR FERNANDEZ JOAQUIN·Filed 2011·Application pending·0 cites
- 0722US9453031B2Chemical entitiesFUNDACIÓN CENTRO NAC DE INVESTIG ONCOLÓGICAS CARLOS III·Filed 2014·Granted Sep 27, 2016·0 cites·17 claims
- 0819US9682991B2Tricyclic compounds for use as kinase inhibitorsPASTOR FERNÁNDEZ JOAQUÍN·Filed 2010·Granted Jun 20, 2017·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Carmen Blanco Aparicio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →